Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Treatment for high blood pressure during pregnancy appears safe and reduces maternal risk

Treatment for high blood pressure during pregnancy appears safe for many women and may reduce maternal risk for severe hypertension without increasing fetal and neonatal risks, according to a new American Heart Association scientific statement published today in the Association's journal Hypertension.

16 Dec 2021

Risk of cardiovascular disease increases with stress and adverse life events, finds study

The risk of cardiovascular disease rises with an increasing burden of perceived stress, financial problems and adverse life events, a major international study with University of Gothenburg researchers as main authors shows. They were able to link the risk of both heart attack and stroke with high stress levels.

16 Dec 2021

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Researchers from the Duke Molecular Physiology Institute have been investigating genetic associations with more severe disease and examining the associations that certain genetic features have with other diseases.

13 Dec 2021

People with HIV more likely to develop heart failure, study finds

People with HIV are at higher risk of developing heart failure than people without HIV, a new study found.

13 Dec 2021

An assessment of COVID-19 mortality risk using patient biomarker time series

A new study discusses the use of multiple biomarkers taken over the course of hospitalization in COVID-19 patients to determine the risk of mortality.

12 Dec 2021

Efficacy of BNT162b2 vaccine booster in reducing mortality due to COVID-19

A recent observational study in Israel evaluates the efficacy of a Pfizer vaccine booster dose in reducing the mortality rate of COVID-19.

12 Dec 2021

Researchers recapitulate the human form of arrhythmogenic cardiomyopathy in zebrafish model

The research groups of Jeroen Bakkers (Hubrecht Institute/UMC Utrecht) and Toon van Veen (UMC Utrecht) bring forward the first patient-specific model for the heart disease arrhythmogenic cardiomyopathy (ACM).

9 Dec 2021

Earlier screening for rare genetic mutation could lead to faster treatment for heart failure in Black Americans

Researchers have linked a rare genetic mutation found mostly in Black Americans and other people of African descent to an earlier onset of heart failure and a higher risk of hospitalization.

8 Dec 2021

Study sheds new light on how certain neurons regulate the number of heart muscle cells

Human heart muscle cells cease to multiply after birth, making any heart injury later in life a permanent one, reducing function and leading to heart failure.

2 Dec 2021

Diabetes medication could revolutionize treatment for heart failure

A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionize treatment, according to new research from the University of East Anglia.

1 Dec 2021

Many long-haul COVID-19 patients may experience breathing issues, chronic fatigue syndrome

Many long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial COVID-19 diagnosis, according to study in JACC: Heart Failure, which is the first of its kind to identify a correlation between long-haul COVID-19 and chronic fatigue syndrome.

29 Nov 2021

Heart failure patients may benefit from common type 2 diabetes drug

Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature Medicine.

29 Nov 2021

Aspirin use associated with raised risk of heart failure

Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition.

23 Nov 2021

Study finds gaps and gender differences in management of type 2 diabetes

Type 2 diabetes is a major risk factor of cardiovascular diseases, such as coronary artery disease and heart failure, as well as premature death. To prevent or at least delay complications, regular health care visits and good control of blood glucose, low-density lipoprotein cholesterol (LDL-C) and other risk factors are needed.

22 Nov 2021

Quality of care declines with private equity ownership of nursing homes, study suggests

Nursing homes acquired by private equity companies saw an increase in emergency room visits and hospitalizations among long-stay residents and an uptick in Medicare costs, according to a new study from Weill Cornell Medicine investigators.

21 Nov 2021

Extreme heat associated with greater risk of adverse cardiovascular incidents

A consequence of global warming is a greater frequency and intensity of extreme heat events. This extreme heat is associated with a greater risk of adverse cardiovascular incidents, especially for adults with pre-existing cardiovascular diseases.

18 Nov 2021

Death from heart attack or stroke may be the first CVD event in some smokers

Death from a heart attack or stroke may be the first cardiovascular disease (CVD) event in some people who smoke cigarettes and CVD is the leading adverse health effect among smokers, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

17 Nov 2021

Study finds lower-quality thrombectomy outcomes for Hispanic ischemic stroke patients

A study involving UT Southwestern neurology researchers found lower-quality outcomes for Hispanic ischemic stroke patients who receive endovascular thrombectomies than for comparable white and Black patients.

17 Nov 2021

EuroEcho 2021 to highlight latest developments in cardiovascular imaging

Get ready for the latest developments in cardiovascular imaging - including gender differences and long COVID - at EuroEcho 2021, a scientific congress of the European Society of Cardiology (ESC).

16 Nov 2021

Drug improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy

Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical trial published in Nature Medicine.